Symbols / VIVE $0.00 +0.00% Viveve Medical, Inc.
VIVE Chart
Stock Fundamentals
|
|
|
|
|
|
About
Official websiteViveve develops and sells healthcare-focused human resources (HR) software solutions designed to streamline and unify HR operations for healthcare organizations. It offers an all-in-one platform that supports recruitment, employee management, and attendance management, aiming to reduce administrative burden and enhance the employee experience throughout their career lifecycle. The company also provides solutions specifically tailored for the healthcare and mental and behavioral health sectors. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.
Ratings
Current target
$0.00
Low
—
High
—
Mean
—
- New number of shares and votes in Vivesto - marketscreener.com Fri, 29 May 2026 06
- NYSE Content Update: Stock Market to Open Like Normal Amid Historic NYC Blizzard - Yahoo Finance Mon, 23 Feb 2026 08
- Healthcare’s hidden ‘dark data’: how eFax turns faxes and scans into AI-ready data - Stock Titan hu, 12 Feb 2026 08
- Is Suja Life's IPO a Refreshing Sip or a Bitter Pill for Investors - Kavout Sat, 11 Apr 2026 00
- DNB Carnegie adjusts Vivesto fair value following reverse stock split - marketscreener.com ue, 26 May 2026 04
- VIVE Stock Price and Chart — OTC:VIVE - TradingView hu, 23 Mar 2023 02
- Vive La France? Stocks Off to a Flier in 2023 - Morningstar ue, 10 Jan 2023 08
- Vivesto trades on Nasdaq Stockholm today following 1: 100 reverse stock split - marketscreener.com Wed, 20 May 2026 07
- Viveve Medical Stock Price Forecast. Should You Buy VIVE? - StockInvest.us ue, 01 Dec 2020 09
- Vive la nouvelle architecture! India, France deepen ties with 21-point roadmap on defence, AI, minerals an - The Economic Times Wed, 18 Feb 2026 08
- CNBC Daily Open: Vive le Softbank and Nvidia's PC push - CNBC Mon, 01 Jun 2026 06
- Vive la Différence: Active Factor Strategies in China A Shares - MSCI Wed, 27 Jun 2018 07
- Health plans detail opportunities, pitfalls of AI at ViVE - Modern Healthcare Mon, 23 Feb 2026 08
- HTC debuts AI-powered Vive Eagle smart glasses to rival Meta, Google, more - Business Standard Mon, 18 Aug 2025 07
- BillionToOne Stock Slumps 13% in February. Analysts Still See $135 Fair Value - TIKR.com ue, 24 Feb 2026 08
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2021-12-31 |
|---|---|---|
| Total Revenue |
|
6.43
|
| Operating Revenue |
|
6.43
|
| Cost Of Revenue |
|
5.81
|
| Reconciled Cost Of Revenue |
|
5.81
|
| Gross Profit |
|
0.62
|
| Operating Expense |
|
22.17
|
| Research And Development |
|
9.66
|
| Selling General And Administration |
|
12.51
|
| Total Expenses |
|
27.98
|
| Operating Income |
|
-21.55
|
| Total Operating Income As Reported |
|
-21.55
|
| EBITDA |
|
-19.63
|
| Normalized EBITDA |
|
-20.62
|
| Reconciled Depreciation |
|
1.14
|
| EBIT |
|
-20.77
|
| Total Unusual Items |
|
0.98
|
| Total Unusual Items Excluding Goodwill |
|
0.98
|
| Special Income Charges |
|
1.36
|
| Other Special Charges |
|
-1.36
|
| Net Income |
|
-22.03
|
| Pretax Income |
|
-21.77
|
| Net Non Operating Interest Income Expense |
|
-1.00
|
| Interest Expense Non Operating |
|
1.00
|
| Net Interest Income |
|
-1.00
|
| Interest Expense |
|
1.00
|
| Other Income Expense |
|
0.78
|
| Other Non Operating Income Expenses |
|
-0.20
|
| Gain On Sale Of Security |
|
-0.37
|
| Tax Rate For Calcs |
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-22.03
|
| Net Income From Continuing Operation Net Minority Interest |
|
-22.03
|
| Net Income From Continuing And Discontinued Operation |
|
-22.03
|
| Net Income Continuous Operations |
|
-22.03
|
| Minority Interests |
|
-0.26
|
| Normalized Income |
|
-23.01
|
| Net Income Common Stockholders |
|
-26.72
|
| Diluted EPS |
|
-2.65
|
| Basic EPS |
|
-2.65
|
| Basic Average Shares |
|
10.09
|
| Diluted Average Shares |
|
10.09
|
| Diluted NI Availto Com Stockholders |
|
-26.72
|
| Earnings From Equity Interest Net Of Tax |
|
-0.26
|
| Preferred Stock Dividends |
|
4.69
|
| Line Item | Trend | 2021-12-31 |
|---|---|---|
| Total Assets |
|
25.91
|
| Current Assets |
|
22.24
|
| Cash Cash Equivalents And Short Term Investments |
|
19.16
|
| Cash And Cash Equivalents |
|
19.16
|
| Receivables |
|
0.55
|
| Accounts Receivable |
|
0.55
|
| Gross Accounts Receivable |
|
0.61
|
| Allowance For Doubtful Accounts Receivable |
|
-0.07
|
| Inventory |
|
1.47
|
| Raw Materials |
|
0.49
|
| Finished Goods |
|
0.98
|
| Prepaid Assets |
|
1.05
|
| Total Non Current Assets |
|
3.67
|
| Net PPE |
|
1.55
|
| Gross PPE |
|
4.30
|
| Accumulated Depreciation |
|
-2.75
|
| Properties |
|
0.00
|
| Machinery Furniture Equipment |
|
0.44
|
| Other Properties |
|
3.75
|
| Leases |
|
0.12
|
| Investments And Advances |
|
0.58
|
| Long Term Equity Investment |
|
0.58
|
| Other Non Current Assets |
|
1.54
|
| Total Liabilities Net Minority Interest |
|
10.85
|
| Current Liabilities |
|
4.53
|
| Payables And Accrued Expenses |
|
3.86
|
| Payables |
|
1.48
|
| Accounts Payable |
|
1.48
|
| Current Accrued Expenses |
|
2.38
|
| Current Debt And Capital Lease Obligation |
|
0.23
|
| Current Capital Lease Obligation |
|
0.23
|
| Current Deferred Liabilities |
|
0.45
|
| Current Deferred Revenue |
|
0.45
|
| Total Non Current Liabilities Net Minority Interest |
|
6.31
|
| Long Term Debt And Capital Lease Obligation |
|
5.12
|
| Long Term Debt |
|
5.12
|
| Other Non Current Liabilities |
|
1.19
|
| Stockholders Equity |
|
15.07
|
| Common Stock Equity |
|
15.07
|
| Capital Stock |
|
0.00
|
| Common Stock |
|
0.00
|
| Share Issued |
|
10.62
|
| Ordinary Shares Number |
|
10.62
|
| Additional Paid In Capital |
|
256.92
|
| Retained Earnings |
|
-241.85
|
| Total Equity Gross Minority Interest |
|
15.07
|
| Total Capitalization |
|
20.19
|
| Working Capital |
|
17.70
|
| Invested Capital |
|
20.19
|
| Total Debt |
|
5.35
|
| Capital Lease Obligations |
|
0.23
|
| Net Tangible Assets |
|
15.07
|
| Tangible Book Value |
|
15.07
|
| Investments In Other Ventures Under Equity Method |
|
0.58
|
| Line Item | Trend | 2021-12-31 |
|---|---|---|
| Operating Cash Flow |
|
-12.88
|
| Cash Flow From Continuing Operating Activities |
|
-12.88
|
| Net Income From Continuing Operations |
|
-22.03
|
| Depreciation Amortization Depletion |
|
1.14
|
| Depreciation |
|
1.14
|
| Depreciation And Amortization |
|
1.14
|
| Other Non Cash Items |
|
0.86
|
| Stock Based Compensation |
|
3.78
|
| Provisionand Write Offof Assets |
|
0.12
|
| Operating Gains Losses |
|
-0.87
|
| Gain Loss On Investment Securities |
|
0.37
|
| Gain Loss On Sale Of PPE |
|
0.11
|
| Change In Working Capital |
|
4.12
|
| Change In Receivables |
|
0.10
|
| Changes In Account Receivables |
|
0.10
|
| Change In Inventory |
|
2.21
|
| Change In Prepaid Assets |
|
-0.02
|
| Change In Payables And Accrued Expense |
|
1.15
|
| Change In Accrued Expense |
|
0.55
|
| Change In Payable |
|
0.60
|
| Change In Account Payable |
|
0.60
|
| Change In Other Current Assets |
|
0.32
|
| Change In Other Current Liabilities |
|
0.36
|
| Investing Cash Flow |
|
-0.46
|
| Cash Flow From Continuing Investing Activities |
|
-0.46
|
| Net PPE Purchase And Sale |
|
-0.46
|
| Purchase Of PPE |
|
-0.46
|
| Capital Expenditure |
|
-0.46
|
| Financing Cash Flow |
|
25.97
|
| Cash Flow From Continuing Financing Activities |
|
25.97
|
| Net Issuance Payments Of Debt |
|
0.00
|
| Issuance Of Debt |
|
0.00
|
| Long Term Debt Issuance |
|
0.00
|
| Net Long Term Debt Issuance |
|
0.00
|
| Net Common Stock Issuance |
|
25.83
|
| Proceeds From Stock Option Exercised |
|
0.22
|
| Net Other Financing Charges |
|
-0.07
|
| Changes In Cash |
|
12.64
|
| Beginning Cash Position |
|
6.52
|
| End Cash Position |
|
19.16
|
| Free Cash Flow |
|
-13.33
|
| Interest Paid Supplemental Data |
|
0.00
|
| Income Tax Paid Supplemental Data |
|
0.00
|
| Common Stock Issuance |
|
25.83
|
| Issuance Of Capital Stock |
|
25.83
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|